Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum

Published:2005-08 Issue:8 Volume:17 Page:837-841
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Guidorizzi de Siqueira Ana Cristina,Cotrim Helma P.,Rocha Raquel,Carvalho Fernando M.,de Freitas Luiz A.R.,Barreto Danyella,Gouveia Leandro,Landeiro Luciana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. Nonalcoholic Steatohepatitis: Definition and Pathology

2. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

3. Nonalcoholic Steatohepatitis

4. Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

5. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin resistance and cardiovascular risk factors in childhood metabolic dysfunction-associated steatotic liver disease;Cukurova Medical Journal;2023-09-30

2. Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients;JGH Open;2020-06-09

3. Nonalcoholic Fatty Liver Disease;Schiff's Diseases of the Liver;2017-10-23

4. Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro;Evidence-Based Complementary and Alternative Medicine;2017

5. Fatty liver in adults receiving antiepileptic medications: relationship to the metabolic risks;Expert Review of Clinical Pharmacology;2016-01-08